Your browser doesn't support javascript.
loading
Heterozygous mutations in SOX2 may cause idiopathic hypogonadotropic hypogonadism via dominant-negative mechanisms.
Cassin, Jessica; Stamou, Maria I; Keefe, Kimberly W; Sung, Kaitlin E; Bojo, Celine C; Tonsfeldt, Karen J; Rojas, Rebecca A; Ferreira Lopes, Vanessa; Plummer, Lacey; Salnikov, Kathryn B; Keefe, David L; Ozata, Metin; Genel, Myron; Georgopoulos, Neoklis A; Hall, Janet E; Crowley, William F; Seminara, Stephanie B; Mellon, Pamela L; Balasubramanian, Ravikumar.
Afiliación
  • Cassin J; Department of Obstetrics, Gynecology, and Reproductive Sciences; Center for Reproductive Science and Medicine; and.
  • Stamou MI; Center for Circadian Biology, University of California, San Diego, La Jolla, California, USA.
  • Keefe KW; Massachusetts General Hospital Harvard Center for Reproductive Medicine and Reproductive Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Sung KE; Center for Infertility and Reproductive Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Bojo CC; Department of Obstetrics, Gynecology, and Reproductive Sciences; Center for Reproductive Science and Medicine; and.
  • Tonsfeldt KJ; Department of Obstetrics, Gynecology, and Reproductive Sciences; Center for Reproductive Science and Medicine; and.
  • Rojas RA; Department of Obstetrics, Gynecology, and Reproductive Sciences; Center for Reproductive Science and Medicine; and.
  • Ferreira Lopes V; Center for Circadian Biology, University of California, San Diego, La Jolla, California, USA.
  • Plummer L; Massachusetts General Hospital Harvard Center for Reproductive Medicine and Reproductive Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Salnikov KB; Massachusetts General Hospital Harvard Center for Reproductive Medicine and Reproductive Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Keefe DL; Center for Infertility and Reproductive Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Ozata M; Massachusetts General Hospital Harvard Center for Reproductive Medicine and Reproductive Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Genel M; Center for Infertility and Reproductive Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Georgopoulos NA; Gulhane School of Medicine, Ankara, Turkey.
  • Hall JE; Section of Pediatric Endocrinology, Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Crowley WF; Division of Endocrinology, Department of Medicine, University of Patras Medical School, Patras, Greece.
  • Seminara SB; National Institute of Environmental Health Sciences, Durham, North Carolina, USA.
  • Mellon PL; Endocrine Unit, Department of Medicine, and Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Balasubramanian R; Massachusetts General Hospital Harvard Center for Reproductive Medicine and Reproductive Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
JCI Insight ; 8(3)2023 02 08.
Article en En | MEDLINE | ID: mdl-36602867
Pathogenic SRY-box transcription factor 2 (SOX2) variants typically cause severe ocular defects within a SOX2 disorder spectrum that includes hypogonadotropic hypogonadism. We examined exome-sequencing data from a large, well-phenotyped cohort of patients with idiopathic hypogonadotropic hypogonadism (IHH) for pathogenic SOX2 variants to investigate the underlying pathogenic SOX2 spectrum and its associated phenotypes. We identified 8 IHH individuals harboring heterozygous pathogenic SOX2 variants with variable ocular phenotypes. These variant proteins were tested in vitro to determine whether a causal relationship between IHH and SOX2 exists. We found that Sox2 was highly expressed in the hypothalamus of adult mice and colocalized with kisspeptin 1 (KISS1) expression in the anteroventral periventricular nucleus of adult female mice. In vitro, shRNA suppression of mouse SOX2 protein in Kiss-expressing cell lines increased the levels of human kisspeptin luciferase (hKiss-luc) transcription, while SOX2 overexpression repressed hKiss-luc transcription. Further, 4 of the identified SOX2 variants prevented this SOX2-mediated repression of hKiss-luc. Together, these data suggest that pathogenic SOX2 variants contribute to both anosmic and normosmic forms of IHH, attesting to hypothalamic defects in the SOX2 disorder spectrum. Our study describes potentially novel mechanisms contributing to SOX2-related disease and highlights the necessity of SOX2 screening in IHH genetic evaluation irrespective of associated ocular defects.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hipogonadismo Tipo de estudio: Prognostic_studies Límite: Adult / Animals / Female / Humans Idioma: En Revista: JCI Insight Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hipogonadismo Tipo de estudio: Prognostic_studies Límite: Adult / Animals / Female / Humans Idioma: En Revista: JCI Insight Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos